PURPOSE We aimed to evaluate the clinical usefulness and outcome of angiosome-oriented percutaneous transluminal angioplasty (IP-PTA) and its clinical outcome for isolated infrapopliteal lesions in diabetic critical limb ischemia.METHODSWe retrospectively reviewed 70 patients (82 limbs) with diabetic critical limb ischemia who had localized disease at the level of the infrapopliteal artery. Patients underwent IP-PTA between January 2011 and December 2013 and were followed up for a mean of 13 months. The primary target arterial lesions were chosen according to the angiosome concept. We evaluated clinical findings, technical success, and patients' clinical outcome. The angiographic outcome of IP-PTA was assessed using the angiosome score. We analyzed the relationship between the angiosome score and the amputation rate. RESULTSThere were 69 anterior tibial artery (ATA) lesions, 70 posterior tibial artery (PTA) lesions, and 58 pe-roneal artery (PA) lesions. The primary target arteries were the ATA (n=43), PTA (n=26), PA (n=2), and ATA + PTA (n=11). We divided the treated limbs into target (n=63) and nontarget (n=19) groups. The overall initial technical success rate was 91.4%. Successful wound healing rates were 87.3% (55/63) and 47.3% (9/19) in the target and nontarget groups, respectively (P < 0.05). CONCLUSIONAngiosome-oriented primary targeted IP-PTA shows a highly effective treatment outcome in di-abetic critical limb ischemia. In cases with inadequate angioplastic results of the target artery, IP-PTA of the nontarget artery should be recommended to improve the limb salvage rates.
Setacci C, de Donato G, Setacci F, Chisci E. Di- abetic patients: epidemiology and global im- pact. J Cardiovasc Surg 2009; 50:263-273.
Wild S, Roglic G, Green A, Sicree R, King H. Glob- al prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27:1047-1053. [CrossRef]
Kim TS, Kang JW, Lee SJ, Huh YJ, Kim HJ. Clinical analysis and results after the amputations of lower extremities due to diabetic foot. J Korean Foot Ankle Soc 2009; 13:50-54.
Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003; 26:491-494. [CrossRef]
Zhan LX, Bharara M, White M, et al. Comparison of initial hemodynamic response after endo- vascular therapy and open surgical bypass in patients with diabetes mellitus and critical limb ischemia. J Vasc Surg 2012; 56:380-386. [CrossRef]
Taylor GI, Pan WR. Angiosomes of the leg: an- atomic study and clinical implications. Plast Reconstr Surg 1998; 102:599-616. [CrossRef]
Alexandrescu V, Vincent G, Azdad K, et al. A re- liable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 2011; 18:376-387. [CrossRef]
Graziani L, Silvestro A, Bertone V, et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33:453-460. [CrossRef]
Setacci C, De Donato G, Setacci F, Chisci E. Isch- emic foot: definition, etiology and angiosome concept. J Cardiovasc Surg 2010; 51:223-231.
Azuma N, Uchida H, Kokubo T, Koya A, Akasaka N, Sasajima T. Factors influencing wound heal- ing of critical ischaemic foot after bypass sur- gery: is the angiosome important in selecting bypass target artery? Eur J Vasc Endovasc Surg 2012; 43:322-328. [CrossRef]
Williams DT, Price P, Harding KG. The influence of diabetes and lower limb arterial disease on cutaneous foot perfusion. J Vasc Surg 2006; 44:770-775. [CrossRef]
Utsunomiya M, Nakamura M, Nakanishi M, et al. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg 2012; 55:113-121. [CrossRef]
Wütschert R, Bounameaux H. Predicting heal- ing of arterial leg ulcers by means of segmen- tal systolic pressure measurements. Vasa 1998; 27:224-228.
Sacks D, Marinelli DL, Martin LG, Spies JB; So- ciety of Interventional Radiology Technology Assessment Committee. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 2003; 14:395-404. [CrossRef]
Medina A, Scott PG, Ghahary A, Tredget EE. Pathophysiology of chronic nonhealing wounds. J Burn Care Rehabil 2005; 26:306-319. [CrossRef]
Söderström M, Albäck A, Biancari F, Lappalain- en K, Lepäntalo M, Venermo M. Angiosome-tar- geted infrapopliteal endovascular revascular- ization for treatment of diabetic foot ulcers. J Vasc Surg 2013; 57:427-435. [CrossRef]
Ferraresi R, Centola M, Ferlini M, et al. Long- term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endo- vasc Surg 2009; 37:336-342. [CrossRef]
Setacci C, de Donato G, Teraa M, et al. Chapter IV: Treatment of critical limb ischemia. Eur J Vasc Endovasc Surg 2011; 42:43-59. [CrossRef]
Manzi M, Cester G, Palena LM, Alek J, Candeo A, Ferraresi R. Vascular imaging of the foot: the first step toward endovascular recanalization. Radiographics 2011; 31:1623-1636. [CrossRef]
Biancari F, Juvonen T. Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2014; 47:517-522. [CrossRef]
Alexandrescu V, Söderström M, Venermo M. Angiosome theory: fact or fiction? Scand J Surg 2012; 101:125-131. [CrossRef]
Odink H, van den Berg A, Winkens B. Technical and clinical long-term results of infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia. J Vasc Interv Radiol 2012; 23:461-467. [CrossRef]
Bae JI, Won JH, Han SH, et al. Endovascular re- vascularization for patients with critical limb ischemia: impact on wound healing and long term clinical results in 189 limbs. Korean J Radi- ol 2013; 14:430-438. [CrossRef]
Kabra A, Suresh KR, Vivekanand V, Vishnu M, Sumanth R, Nekkanti M. Outcomes of angio- some and non-angiosome targeted revascu- larization in critical lower limb ischemia. J Vasc Surg 2013; 57:44-49. [CrossRef]